News & Discoveries

October 14, 2020

‘Dark Matter’ DNA Linked to Cell-Specific Patterns of Gene ActivityUCSF researchers are finding new clues to how neuropsychiatric disorders unfold by focusing on the role of a little-studied form of DNA in early brain development.

October 09, 2020

First-Ever Attempt at Cell Therapy for Marine Mammals with Epilepsy Stems from Decades of Research and a Unique Bay Area CollaborationA cellular therapy for epilepsy developed at UCSF has been employed for the first time in a sea lion with intractable seizures caused by ingesting toxins from algal blooms.

October 06, 2020

The UCSF researchers — whose work spans investigations into autism spectrum disorder (ASD), oncology, and mitochondrial disease — were among 85 awardees for the grants that the NIH says “will fund highly innovative and unusually impactful biomedical or behavioral research proposed by extraordinarily creative scientists.”

September 21, 2020

Broader Smiles in Participants’ Selfies Made Shift in Perspective VisibleOlder adults who took weekly 15-minute “awe walks” for eight weeks reported increased positive emotions and less distress in their daily lives.

September 07, 2020

Stable Recordings Let Brain and Machine Learning System Build ‘Partnership’ Over TimeThe achievement of “plug and play” performance demonstrates the value of so-called ECoG electrode arrays for BCI applications.

September 01, 2020

Though FTD is not as well known as Alzheimer’s disease, it’s the second most common cause of dementia in people under 65, and there’s currently no treatment.

August 31, 2020

Results Lay Groundwork for New, More Targeted Immune TherapiesNew UCSF research sheds light on how immune system B cells that infiltrate the central nervous system may drive multiple sclerosis.

August 26, 2020

Study Reveals the Second X Chromosome Confers ProtectionUCSF scientists now have evidence from research that women with Alzheimer’s live longer than men with the disease because they have genetic protection from the ravages of the disease.

August 06, 2020

Potential General-Purpose Learning Aid Could Have Many Medical and Consumer ApplicationsNew research by neuroscientists at the University of Pittsburgh and UC San Francisco revealed that a simple, earbud-like device developed at UCSF that imperceptibly stimulates a key nerve leading to the brain could significantly improve the wearer’s ability to learn the sounds of a new language.

August 05, 2020

A newly completed phase 3, multicenter clinical trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis (RMS) – the most common form of the illness, in which symptoms wax and wane.